首页 > 市场调查报告书 > 医疗设备

整形外科手术用器具

市场调查报告书

商品编码

1345446

全球脊柱后侧凸市场 - 2023-2030

Global Kyphoscoliosis Market - 2023-2030

出版日期: 2023年09月06日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年，全球脊柱后侧凸市场规模达到29亿美元，预计到2030年将达到42亿美元，2023-2030年预测期间复合年增长率为5.1%。

脊柱后侧凸是脊柱在两个平面上的异常弯曲：冠状面（或从一侧到另一侧）和矢状面（或从后到前）。这是另外两种疾病的综合脊柱异常：脊柱后凸和脊柱侧凸。脊柱侧凸会导致冠状面曲率异常，从而导致脊柱水平弯曲。

由于在矢状面上不正确地向前或向后扭转，脊柱后凸会导致背部看起来呈圆形或下垂。患者特定植入物和手术规划工具的开发通常在 3D 打印和计算机辅助设计的帮助下，可以通过为每位患者定製手术来改善手术结果。治疗选择包括物理治疗、支具治疗，在严重的情况下还包括手术治疗。这些手术旨在减少不适，同时改善姿势和活动能力。

动力学

神经系统疾病的兴起

神经系统疾病会影响肌肉控制、协调和一般神经肌肉功能，因此很容易影响脊柱后侧凸的发生和演变。包括肌营养不良症和脊髓性肌萎缩症在内的神经系统疾病经常伴有肌肉无力。薄弱的肌肉无法为脊柱提供必要的支撑来维持其自然姿势和弯曲。这种弱化可能会导致非典型的脊柱弯曲，例如脊柱后侧凸。

一些神经系统疾病，例如脊髓肿瘤或创伤，可以直接压迫脊髓或使其受伤。通过干扰控制肌肉功能和姿势的常规大脑脉衝，这种压迫有可能导致脊柱异常，例如脊柱后侧凸。因此，神经系统疾病的增加将推动市场增长。

例如，根据联合国最近的一份报告，多达10 亿人，即世界人口的近六分之一，患有神经系统疾病，包括偏头痛、脑损伤和神经感染，以及阿尔茨海默氏症和帕金森氏症、中风等疾病、多发性硬化症和癫痫症。每年有 680 万人遭受这些疾病的折磨。因此，神经系统疾病的增加促进了市场的快速扩张。

治疗技术的进步

脊柱后侧凸的诊断、治疗和管理都极大地受益于技术进步。这些进展增加了我们对这种疾病的了解，提高了诊断能力，并提供了更好的治疗选择。

例如，一种常见的医疗设备，特别是在脊柱手术中，是 MAGEC 系统。为了减缓脊柱侧凸的进展，脊柱在生长过程中受到支撑。接受这种治疗的患者中，儿童患者占很大一部分。 2020 年 2 月 13 日发布了安全通知，以回应 MAGEC 系统 Model X 桿中执行器端盖植入后分离的投诉。数据评估显示，约0.5%的设备发生执行器端盖分离，促使医生停止所有系统植入。

医生被警告说，端盖分离后，植入物可能会变得鬆动、腐蚀、迁移或引起疼痛，并且桿在充当内部支架时可能会继续延伸或分散。这可能会导致执行器的内部组件暴露，从而加速其老化，并导致钛合金、磨损碎片和局部组织变色进入系统。

与治疗相关的副作用

脊柱后侧凸可以通过多种方式治疗，包括支具、物理治疗和手术，具体取决于病情的严重程度和患者的具体需求。每种治疗形式都有一些潜在的副作用和具体的注意事项。长时间佩戴支具可能会导致皮疹、擦伤或压疮。

填充和适当的贴合可以缓解这个问题。物理治疗练习可能会导致肌肉酸痛，尤其是在开始新的锻炼程序时。手术后几週或几个月内，患者可能会在手术部位感到疼痛和不适。疼痛控制是术后护理的重要组成部分。

如需报告的更多详细信息，索取样品

Overview

Global Kyphoscoliosis Market reached US$ 2.9 billion in 2022 and is expected to reach US$ 4.2 billion by 2030, growing with a CAGR of 5.1% during the forecast period 2023-2030.

Kyphoscoliosis is an abnormal curve of the spine on two planes: the coronal plane, or side to side, and the sagittal plane, or back to front. It's a combined spinal abnormality of two other conditions: kyphosis and scoliosis. Scoliosis causes an abnormal coronal plane curvature, which causes the spine to curve horizontally.

By improperly twisting forward or backward on the sagittal plane, kyphosis causes the back to seem rounded or fell. The development of patient-specific implants and surgical planning tools, typically assisted by 3D printing and computer-assisted design, can improve surgical outcomes by customising operations for each patient. Treatment options include physical therapy, bracing, and in severe situations, surgery. These procedures aim to reduce discomfort while also improving posture and mobility.

Dynamics

The Rise of Neurological Disorders

Neurological disorders can easily influence the onset and evolution of kyphoscoliosis due to their effects on muscle control, coordination, and general neuromuscular function. Neurological diseases including muscular dystrophy and spinal muscular atrophy frequently present with muscle weakness. Weak muscles are unable to provide the spine with the necessary support to maintain its natural posture and curvature. Atypical spinal curvatures, such kyphoscoliosis, may arise as a result of this weakening.

Some neurological conditions, such as spinal cord tumours or trauma, can directly compress the spinal cord or injure it. By interfering with the regular brain impulses that control muscle function and posture, this compression has the potential to result in spinal anomalies such kyphoscoliosis. Therefore, the increase of neurological disorders will boost market growth.

For instance, according to a recent United Nations report, up to 1 billion people, or nearly one in six of the world's population, suffer from neurological disorders, including migraine, brain injuries, and neuroinfections as well as diseases like Alzheimer's and Parkinson's, stroke, multiple sclerosis, and epilepsy. Each year, 6.8 million people suffer as a result of these illnesses. Thus, the rise in neurological conditions contributes to the market's rapid expansion.

Technological Advancements in the Treatment

The diagnosis, treatment, and management of kyphoscoliosis have all benefited greatly from technological improvements. These developments have increased our understanding of the disorder, improved the capacity to diagnose it, and provided better therapy options.

For instance, a common medical device, particularly in spinal surgery, is the MAGEC system. In order to slow the progression of scoliosis, the spine is braced during growth. Paediatric patients make up a large portion of the patients receiving this treatment. A safety notice was issued on February 13, 2020, in response to complaints of post-implantation separation of an actuator end cap in MAGEC system Model X rods. The data evaluation revealed that the actuator end cap separation had happened in about 0.5% of the devices, prompting doctors to stop all system implantations.

Physicians have been cautioned that after the end cap has separated, the implant may become loose, corrode, migrate, or cause pain, and that the rod may continue to extend or distract while acting as an internal brace. This could result in the actuator's internal components becoming exposed, which could speed their deterioration and allow titanium alloy, wear debris, and localised tissue discoloration to enter the system.

Side Effects Associated with the Treatment

Kyphoscoliosis can be treated in a number of ways, including bracing, physical therapy, and surgery, depending on the severity of the condition and the patient's specific needs. There are several potential side effects and considerations specific to each form of treatment. An extended period of wearing a brace may result in skin rashes, chafing, or pressure sores.

Padding and a proper fit could mitigate this issue. Physical therapy exercises may cause muscle soreness, especially when starting a new exercise routine. Patients may experience pain and discomfort at the surgical site for several weeks or months after the procedure. Pain control is a crucial part of postoperative care.

Segment Analysis

The global kyphoscoliosis market is segmented based on type, disease management, age group, end user and region.

Kyphoscoliosis can Affect Children more Easily than Adults

Kyphoscoliosis can affect children more easily than adults due to a number of issues associated to the developing spine and musculoskeletal system during childhood and adolescence. For instance, certain children have a higher risk of developing kyphoscoliosis due to congenital spine abnormalities. These anomalies might not be identified until the child's spine begins to grow and develop.

The ligaments and soft tissues that surround the spine also grow swiftly in children and teenagers. These structures may not develop properly or expand at different rates, which can cause kyphoscoliosis. Children and teenagers are more likely to participate in activities that strain the spine excessively or adopt poor postural habits. Large backpacks, protracted use of electronic gadgets while hunched over, and various badly performed tasks can strain the spine and possibly result in kyphoscoliosis. Thus, all of those factors contribute to accelerating segment expansion.

Geographical Penetration

Rising Product Approvals and Prevalence of Disease in the North American Region

A mix of historical, economic, and societal factors have contributed to the great advancement of healthcare services in North America, especially in the United States and Canada. In North America, regulatory organisations like the Food and Drug Administration (FDA) in the United States and Canada set strict guidelines for the effectiveness and safety of medications and medical devices. These organisations aid in ensuring that only secure and efficient medications are distributed.

Moreover, numerous medical research organisations, academic institutes, and healthcare facilities located in North America are at the forefront of spine-related research. To learn more about the origins, risk factors, and available treatments for kyphoscoliosis, researchers in the area are actively researching the condition. Clinical trials are required because of this area of research interest. North America is the perfect site for conducting clinical trials due to its sophisticated healthcare system and medical technologies. Clinical research can be carried out with the help of modern facilities, qualified medical personnel, and advanced imaging technology. Thus, all of these variables contribute to the region's growth.

COVID-19 Impact Analysis

Many healthcare systems had issues and delays in non-urgent care during the pandemic, including the diagnosis and treatment of kyphoscoliosis. Routine tests, imaging, and elective treatments were postponed or cancelled in a number of locations, which would have delayed the diagnosis and treatment of some patients.

Patients who rely on orthopaedic braces for their kyphoscoliosis therapy may have experienced difficulties getting their braces fitted, adjusted, or replaced when hospitals cut back on their services or during lockdowns. This could impact the effectiveness of bracing therapies. During periods of high COVID-19 activity, elective treatments, such as those to treat kyphoscoliosis, were routinely delayed to save money on medical services and reduce the risk of viral transmission in hospitals. As a result, individuals who require surgery could have to wait longer.

By Type

Scoliosis
Kyphosis
- Postural kyphosis
- Scheuermann's kyphosis
- Age-related kyphosis
- Congenital kyphosis

By Disease Management

Diagnosis
- MRI
- CT Scan
- Bone Density Testing
- Others

Medication
Surgery
- Spinal Implants
- Bone Grafts
- Braces and Orthotics
- Others

By Age Group

Children
Adults

By End User

Hospitals
Clinics
Ambulatory Surgical Centers

By Region

North America
- U.S.
- Canada
- Mexico

Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe

South America
- Brazil
- Argentina
- Rest of South America

Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific

Middle East and Africa

Key Developments

On July 05, 2022, an advanced surgery was recently performed by a skilled team of surgeons from the city's top multispecialty hospital, SIMS Hospital India, to treat a severe case of kyphoscoliosis. The spine surgery community refers to the 15-year-old Ethiopian patient, Master Tesfaye Mengesha Mersha, who has severe kyphoscoliosis, as having a "Anaconda Spine," a 110-degree deformity of the upper spine in the chest area.
On September 22, 2021, the first surgical procedure in the BRAIVE IDE study, which will assess the safety and efficacy of the BraiveTM growth modulation system for the treatment of progressive juvenile (JIS) or adolescent (AIS) idiopathic scoliosis, has been completed, according to Medtronic plc, the world leader in medical technology.

Competitive Landscape

The major global players in the market include Koninklijke Philips N.V., Canon, GE Healthcare, Siemens, Hologic, Sri Krishna Pharmaceuticals Ltd, NEXGEN PHARMA INC, ValiantLabs.in., BASF Corporation, Dr. Reddy's Laboratories Ltd and among others.

Why Purchase the Report?

To visualize the global kyphoscoliosis market segmentation based on type, disease management, age group, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of kyphoscoliosis market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global kyphoscoliosis market report would provide approximately 61 tables, 58 figures and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Disease Management
3.3. Snippet by Age Group
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. The rise of Neurological disorders
  - 4.1.1.2. Technological advancements in the Treatment
4.2. Restraints
- 4.2.2. Opportunity
- 4.2.3. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Scoliosis *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Kyphosis
- 7.3.1. Postural kyphosis
- 7.3.2. Scheuermann's kyphosis
- 7.3.3. Age-related kyphosis
- 7.3.4. Congenital kyphosis

8. By Disease Management

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
- 8.1.2. Market Attractiveness Index, By Disease Management
8.2. Diagnosis*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  - 8.2.2.1. MRI
  - 8.2.2.2. CT Scan
  - 8.2.2.3. Bone Density Testing
  - 8.2.2.4. Others
8.3. Medication
8.4. Surgery
- 8.4.1. Spinal Implants
- 8.4.2. Bone Grafts
- 8.4.3. Braces and Orthotics
- 8.4.4. Others

9. By Age Group

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 9.1.2. Market Attractiveness Index, By Age Group
9.2. Children*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Adults

10. By End User

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Clinics
10.4. Ambulatory Surgical Centres

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End Users
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.6.1. U.S.
  - 11.2.6.2. Canada
  - 11.2.6.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Management
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles (1-5 Diagnosis Device Manufacturers & 6-10 Drug Manufacturers)

13.1. Koninklijke Philips N.V. *
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Canon
13.3. GE Healthcare
13.4. Siemens
13.5. Hologic
13.6. Sri Krishna Pharmaceuticals Ltd
13.7. NEXGEN PHARMA INC
13.8. ValiantLabs.in.
13.9. BASF Corporation
13.10. Dr. Reddy's Laboratories Ltd

LIST NOT EXHAUSTIVE